Friday, October 16, 2020 11:30:24 AM
What I dont get is why they wont attempt to finish the IV Clinical Trial. Just "OK got some good data on 102, we've done enough, dont need 150, in their opinion".
Are they going to settle for EUA only. Its a "safety/ futility review with a "go ahead with more Trial till finished/ stop for S or F / Enough data on you unfinished Phase 2b-no Phase 3 needed". They should have finished recruiting and finished the Trial, IMO. I dont like Their going all in with an unfinished Trial, JMHFO...
Hope their new CRO guy gets patients enrolled to finish that Trial and does better with the Inhaler. Sure Phase 2b Placebo Trials are tough, but not finishing this Trial? Maybe they'll at least get the EUA, BUT???
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • Oct 3, 2024 7:00 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM
Unitronix Corp Unveils Cryptocurrency Investment Portfolio Strategy • UTRX • Oct 2, 2024 8:40 AM